We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Wins New Jersey Court Ruling for Two Enbrel Patents
Amgen Wins New Jersey Court Ruling for Two Enbrel Patents
A federal district court in New Jersey dealt a blow on Friday to Novartis division Sandoz’s efforts to invalidate two patents for Amgen’s inflammatory disorder treatment Enbrel (etanercept).